美国FDA药品数据库（U.S. FDA Drugs Database）
检索条件:" 药品名称=DABIGATRAN ETEXILATE MESYLATE"
符合检索条件的记录共 29 条
共 2 页，当前第 1 页
下一页 最后一页 返回检索页 可点击列名称排序
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
DABIGATRAN ETEXILATE MESYLATE 208057 001 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 75MG BASE No No 2017/04/19 (TA) -- TEVA PHARMS USA None (Tentative Approval)
DABIGATRAN ETEXILATE MESYLATE 208057 002 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 110MG BASE No No 2017/04/19 (TA) -- TEVA PHARMS USA None (Tentative Approval)
DABIGATRAN ETEXILATE MESYLATE 208057 003 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2017/04/19 (TA) -- TEVA PHARMS USA None (Tentative Approval)
DABIGATRAN ETEXILATE MESYLATE 208040 001 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 75MG BASE No No 2020/03/11 2020/03/11 ALKEM LABS LTD Prescription
DABIGATRAN ETEXILATE MESYLATE 208040 001 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 75MG BASE No No 2020/03/11 (TA) 2020/03/11 ALKEM LABS LTD Prescription
DABIGATRAN ETEXILATE MESYLATE 208040 002 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2020/03/11 2020/03/11 ALKEM LABS LTD Prescription
DABIGATRAN ETEXILATE MESYLATE 208040 002 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2020/03/11 (TA) 2020/03/11 ALKEM LABS LTD Prescription
DABIGATRAN ETEXILATE MESYLATE 207961 001 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 75MG BASE No No 2020/05/06 2020/05/06 HETERO LABS LTD III Prescription
DABIGATRAN ETEXILATE MESYLATE 207961 001 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 75MG BASE No No 2020/05/06 (TA) 2020/05/06 HETERO LABS LTD III Prescription
DABIGATRAN ETEXILATE MESYLATE 207961 002 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2020/05/06 2020/05/06 HETERO LABS LTD III Prescription
DABIGATRAN ETEXILATE MESYLATE 207961 002 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2020/05/06 (TA) 2020/05/06 HETERO LABS LTD III Prescription
DABIGATRAN ETEXILATE MESYLATE 208048 001 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 75MG BASE No No 2020/10/26 (TA) -- DR REDDYS LABS LTD None (Tentative Approval)
DABIGATRAN ETEXILATE MESYLATE 208048 002 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 110MG BASE No No 2020/10/26 (TA) -- DR REDDYS LABS LTD None (Tentative Approval)
DABIGATRAN ETEXILATE MESYLATE 208048 003 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2020/10/26 (TA) -- DR REDDYS LABS LTD None (Tentative Approval)
DABIGATRAN ETEXILATE MESYLATE 207984 001 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 75MG BASE No No 2020/12/18 (TA) -- GLENMARK PHARMS LTD None (Tentative Approval)
DABIGATRAN ETEXILATE MESYLATE 207984 002 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 110MG BASE No No 2020/12/18 (TA) -- GLENMARK PHARMS LTD None (Tentative Approval)
DABIGATRAN ETEXILATE MESYLATE 207984 003 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL EQ 150MG BASE No No 2020/12/18 (TA) -- GLENMARK PHARMS LTD None (Tentative Approval)
DABIGATRAN ETEXILATE MESYLATE 208067 002 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL 150MG No No 2022/01/21 (TA) -- MYLAN PHARMS INC None (Tentative Approval)
DABIGATRAN ETEXILATE MESYLATE 207922 002 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL 110MG No No 2022/03/21 (TA) -- BRECKENRIDGE PHARMS None (Tentative Approval)
DABIGATRAN ETEXILATE MESYLATE 207922 003 ANDA DABIGATRAN ETEXILATE MESYLATE CAPSULE;ORAL 150MG No No 2022/03/21 (TA) -- BRECKENRIDGE PHARMS None (Tentative Approval)
药品名称，活性成分，申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database